Ceva Animal Health, which develops and produces vaccines primarily for the poultry industry, is expanding into the swine market. Earlier this year the company announced it was entering the equine market.
The two new divisions come as Ceva completed its 2013 acquisition of companion animal health company Sogeval Laboratories, the Kansas City Business Journal reported. Ceva's North American headquarters are located in Lenexa, KS.
"The vision for this has been in the works for probably 10 years," Craig Wallace, the company's director of North America operations, told the Business Journal. "And we have been talking about the personnel side and infrastructure needs to enter the market since 2011. We've really started accelerating that process."
Last month, the company committed to spending $8.3 million to expand its U.S. operations and beef up its Lenexa facility. In 2005, Ceva bought Biomune and spent $7 million on expanding that company's former R&D facility.
Ceva Animal Health is the American branch of Ceva Sante Animale, which was founded in 1999, when the former Sanofi-Aventis subsidiary completed the first of four leveraged buyouts. Ceva Sante Animale is based out of Libourne, France.
- here's the KCBJ story
Special Report: Top 10 animal health companies of 2013 - Ceva Animal Health